247 related articles for article (PubMed ID: 12871162)
1. DNA topoisomerases as targets for antiprotozoal therapy.
Bakshi RP; Shapiro TA
Mini Rev Med Chem; 2003 Sep; 3(6):597-608. PubMed ID: 12871162
[TBL] [Abstract][Full Text] [Related]
2. DNA topoisomerases in life and death: implications in kinetoplastid protozoa.
Chowdhury AR; Majumder HK
Curr Mol Med; 2004 Sep; 4(6):711-22. PubMed ID: 15357219
[TBL] [Abstract][Full Text] [Related]
3. Scientific hypothesis: a new strategy for the design of anti-protozoal drugs--DNA polymerase as a drug target.
Biñas M; Johnson AM
Appl Parasitol; 1994 Sep; 35(3):157-68. PubMed ID: 7951392
[TBL] [Abstract][Full Text] [Related]
4. Targeting polyamines of parasitic protozoa in chemotherapy.
Müller S; Coombs GH; Walter RD
Trends Parasitol; 2001 May; 17(5):242-9. PubMed ID: 11323309
[TBL] [Abstract][Full Text] [Related]
5. Targeting DHFR in parasitic protozoa.
Anderson AC
Drug Discov Today; 2005 Jan; 10(2):121-8. PubMed ID: 15718161
[TBL] [Abstract][Full Text] [Related]
6. Peptide deformylase of eukaryotic protists: a target for new antiparasitic agents?
Meinnel T
Parasitol Today; 2000 Apr; 16(4):165-8. PubMed ID: 10725904
[TBL] [Abstract][Full Text] [Related]
7. [Target points of antiparasitic drugs].
Boczoń K
Wiad Parazytol; 1988; 34(4-6):529-43. PubMed ID: 3071915
[No Abstract] [Full Text] [Related]
8. DNA Topoisomerases of Leishmania Parasites; Druggable Targets for Drug Discovery.
Reguera RM; Elmahallawy EK; García-Estrada C; Carbajo-Andrés R; Balaña-Fouce R
Curr Med Chem; 2019; 26(32):5900-5923. PubMed ID: 29773051
[TBL] [Abstract][Full Text] [Related]
9. Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets.
Coombs GH; Goldberg DE; Klemba M; Berry C; Kay J; Mottram JC
Trends Parasitol; 2001 Nov; 17(11):532-7. PubMed ID: 11872398
[TBL] [Abstract][Full Text] [Related]
10. The cell cycle of parasitic protozoa: potential for chemotherapeutic exploitation.
Hammarton TC; Mottram JC; Doerig C
Prog Cell Cycle Res; 2003; 5():91-101. PubMed ID: 14593704
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrion of protozoan parasite emerges as potent therapeutic target: exciting drugs are on the horizon.
Sen N; Majumder HK
Curr Pharm Des; 2008; 14(9):839-46. PubMed ID: 18473833
[TBL] [Abstract][Full Text] [Related]
12. The essential features of microorganisms and the rationale for antimicrobial therapy.
Douglas CW
Br Dent J; 1992 May; 172(9):339-43. PubMed ID: 1389584
[TBL] [Abstract][Full Text] [Related]
13. Demystifying the potential of inhibitors targeting DNA topoisomerases in unicellular protozoan parasites.
Lamba S; Roy A
Drug Discov Today; 2023 Jun; 28(6):103574. PubMed ID: 37003515
[TBL] [Abstract][Full Text] [Related]
14. Protein kinases as targets for anti-parasitic chemotherapy.
Doerig C
Biochim Biophys Acta; 2004 Mar; 1697(1-2):155-68. PubMed ID: 15023358
[TBL] [Abstract][Full Text] [Related]
15. Novel findings on trypanosomatid chemotherapy using DNA topoisomerase inhibitors.
Díaz-González R; Pérez-Pertejo Y; Prada CF; Fernández-Rubio C; Balaña-Fouce R; Reguera RM
Mini Rev Med Chem; 2009 Jun; 9(6):674-86. PubMed ID: 19519493
[TBL] [Abstract][Full Text] [Related]
16. Understanding drug resistance in human intestinal protozoa.
El-Taweel HA
Parasitol Res; 2015 May; 114(5):1647-59. PubMed ID: 25782683
[TBL] [Abstract][Full Text] [Related]
17. Topoisomerases of kinetoplastid parasites as potential chemotherapeutic targets.
Das A; Dasgupta A; Sengupta T; Majumder HK
Trends Parasitol; 2004 Aug; 20(8):381-7. PubMed ID: 15246322
[TBL] [Abstract][Full Text] [Related]
18. DNA topoisomerases and their poisoning by anticancer and antibacterial drugs.
Pommier Y; Leo E; Zhang H; Marchand C
Chem Biol; 2010 May; 17(5):421-33. PubMed ID: 20534341
[TBL] [Abstract][Full Text] [Related]
19. Development of cysteine protease inhibitors as chemotherapy for parasitic diseases: insights on safety, target validation, and mechanism of action.
McKerrow JH
Int J Parasitol; 1999 Jun; 29(6):833-7. PubMed ID: 10480720
[TBL] [Abstract][Full Text] [Related]
20. Nitroheterocyclic drugs with broad spectrum activity.
Raether W; Hänel H
Parasitol Res; 2003 Jun; 90 Supp 1():S19-39. PubMed ID: 12811546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
